Transdermal delivery of ketorolac

Yakugaku Zasshi

Volumn 129, Issue 3, 2009, Pages 373-379

  Amrish, Chandra ^a   Kumar, Sharma Pramod ^b  

^a BUNDELKHAND UNIVERSITY   (India)

^b RV Northland Institute   (India)

Author keywords

Abrasive; Ketorolac; Penetration enhancer; Pretreatment; Skin

Indexed keywords

2 PROPANOL; ACETIC ACID; CARRAGEENAN; DIETHYLENE GLYCOL MONOETHYL ETHER; DIMETHYL SULFOXIDE; EUCALYPTUS OIL; HYDROXYPROPYLMETHYLCELLULOSE; KETOROLAC; LIMONENE; METHOCEL K15; PHOSPHATE BUFFERED SALINE; POLYMER; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG PENETRATION; DRUG RELEASE; GEL; HISTOPATHOLOGY; IN VITRO STUDY; NONHUMAN; PAW EDEMA; PH; RAT; SKIN PERMEABILITY; STATISTICAL ANALYSIS; TRANSDERMAL PATCH; WRITHING TEST;

ADMINISTRATION, CUTANEOUS; ANALGESICS; ANIMALS; DRUG DELIVERY SYSTEMS; EUCALYPTUS; GELS; KETOROLAC; MONOTERPENES; OILS, VOLATILE; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SKIN; SKIN ABSORPTION;

EID: 63049085607     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.129.373     Document Type: Article

References (26)

1. Buckley M., Brogden R., Drug, 39, 86-109 (1990).
2. Rooks W., Maloney P., Shott L., Schuler M., Sevelius H., Strosberg A., Tanenbaum L., Tomolonis A., Wallach M., Waterbury D., Yee J., Drugs Exp. Clin. Res., 11, 479-492 (1985).
3. Tiwari S. B., Udupa N., Int. J. Pharm., 260, 93-103 (2003).
4. Roy S. D., Manoukian E., Combs D., J. Pharm. Sci., 84, 49-52 (1995).
5. Cho Y. A., Gwak H. S., Drug Dev. Ind. Pharm., 30, 557-564 (2004).
6. Tiwari S. B., Pai R. M., Udupa N., Drug Deliv., 11, 47-51 (2004).
7. Chavez R., Bravo C., Zazueta C., Pichardo J., Uribe A., Corona N., Reyes-Vivas H., Gonzalez C., Chavez E., J. Pharmacol. Exp. Ther., 267, 1134-1139 (1993).
8. Kim B., Doh H., Le T. N., Cho W., Yong C., Choi H., Kim J. S., Lee C., Kim D., Int. J. Pharm., 293, 193-202 (2005).
9. Doh, H., Cho, W., Yong, C., Choi, H., Kim J. S., Lee C., Kim D., J. Pharm. Sci., 92, 1008-1017 (2003).
10. Draize, J. H., Dermal Toxicity in Appraisal of the Safety of Chemicals in Foods, Drugs and Cosmetics. The Association of Food and Drug Officials of the United States, Bureau of Food and Drugs, Austin Texas, 1959, pp. 46-59.
11. Alol A., Kuriyama K., Shimizu T., Yoshioka M., Int. J. Pharm., 93, 1-6 (1993).
12. Williams A. C., Barry B. W., Int. J. Pharm., 74, 157-168 (1991).
13. Barry, B. W., J. Contr. Rel., 6, 85-97 (1987).
14. Ganem A.-Q., Lafforgue A. C., Falson-Rieg B. P., Int. J. Pharm., 147, 165-172 (1997).
15. Lee T. W., Kim J. C., Hwangl S. J., Eur. J. Pharm. Biopharm., 56, 407-412 (2003).
16. Mura P., Faucci M. T., Bramanti G., Corti P., Eur. J. Pharm. Sci., 9, 365-372 (2000).
17. Touitou E., Levy F.-S., Dayan N., Alhaique F., Riccieri F., Int. J. Pharm., 103, 131-136 (1994).
18. Watkinson A. C., Hadgraft J., Bye A., Int. J. Pharm., 74, 229-236 (1991).
19. Godwin D. A., Kim N. H., Felton L. A., Eur. J. Pharm. Biopharm., 53, 23-27 (2002).
20. Williams A. C., Barry B. W., Int. J. Pharm., 57, R7-R9 (1989).
21. Okabe H., Takayama K., Ogura A., Nagai T., Drug Des. Deliv., 4, 313-321 (1989).
22. Cornwell P. A., Barry B. W., J. Pharm. Pharmacol., 46, 261-269 (1994).
23. Cornwell P. A., Barry B. W., Bouwstra J. A., Gooris G. S., Int. J. Pharm, 27, 9-26 (1996).
24. Ronaldo A., Mariana L., Sara M., Adriana B., Steve P., Ferreira S., Fernando Q., Eur. J. Pharmacol., 387, 111-118 (2000).
25. Voilley N., Current Drug Targets - Inflammation, Allergy, 3, 71-79 (2004).
26. Vogel H., Vogel W., Pharmacological Assays. In: Drug Discovery and Evaluation: Springer Verlag, Germany, 1997, pp. 368-370.